Blog


Award for being one of the top 25 COPD blogs on the planet

Wow, we’ve just received an award from Feedspot, for being one of the top COPD blogs on the planet. We were ranked on the following criteria: Google reputation and Google search ranking Influence and popularity on Facebook, twitter and other social media sites Quality and consistency of posts. Feedspot’s editorial […]


Managing elderly patients with COPD through empowerment

Demographic, familial, and social factors have important roles in the process of empowering elderly patients with chronic obstructive pulmonary disease (COPD), according to a study published in PLoS One. For elderly patients with COPD, empowerment techniques are central to reducing the severity or frequency of exacerbations, preventing hospitalization, and improving […]


Real-World Observational Study Will Aid in Understanding of Progression of COPD

A new collaboration between the Duke Clinical Research Institute, Duke University’s MURDOCK Study, and Boehringer Ingelheim Pharmaceuticals Inc will try to better understand how chronic obstructive pulmonary disease progresses in the real world. See more at: http://www.ajmc.com/newsroom/real-world-observational-study-will-aid-in-understanding-of-progression-of-copd#sthash.BQsjE9Ti.dpuf


“What are my chances of developing COPD if one of my parents has the disease?”

“What are my chances of developing COPD if one of my parents has the disease?” A systematic review and meta-analysis of prevalence of co-occurrence of COPD diagnosis in parents and offspring Authors Li LSK, Paquet C, Johnston K, Williams MT Published International Journal of Chronic Obstructive Pulmonary Disease 24 January […]


The disease burden of chronic obstructive pulmonary disease in Greece

This survey provides insightful data regarding the impact of COPD on Greek patients’ everyday life, psychology, and productivity, revealing the increased individual morbidity and the significant burden of this condition on society. International Journal of Chronic Obstructive Pulmonary Disease, 2016 Volume 2016:11(1) Pages 2179—2189 Authors Kourlaba G, Hillas G, Vassilakopoulos T, […]


Triple-combination therapy reduces COPD exacerbations

GlaxoSmithKline and Innoviva’s triple-combination therapy of fluticasone furoate, umeclidinium and vilanterol significantly reduced the amount of exacerbations experienced by patients with chronic obstructive pulmonary disease compared with AstraZeneca’s Symbicort Turbohaler, according to phase 3 study results presented at the 2016 European Respiratory Society International Congress. Results showed that patients in […]


Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice

Guidelines on the management of chronic obstructive pulmonary disease (COPD) are based on numerous randomized, controlled trials of efficacy, which are usually generated for registration purposes. However, these trials have included patients who were selected with the use of strict criteria and were closely monitored, and therefore the results have […]


Pulmonary rehabilitation as a mechanism to reduce hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis

Abstract Background  Acute exacerbations of COPD (AECOPD) have a significant impact on healthcare utilization, including physician visits and hospitalizations. Previous studies and reviews have shown that pulmonary rehabilitation has many benefits but the effect on hospitalizations for AECOPD is inconclusive. Methods  A literature search was carried out to find studies […]